EUCTR2021-001069-20-ES进行中（未招募）1 期
Tolerability and acceptance of two oral hydrocortisone compounding formulation for pediatrics
Vall d'Hebron Hospital Universitari0 个研究点目标入组 35 人开始时间: 2021年8月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Outpatients of both sexes, = 6 years of age without swallowing problems and up to 17 years, at the time of signing the informed consent document by parent (s) or guardian (s) and / or patients.
- •- Diagnosis of adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 35
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Known hypersensitivity to any of the excipients in the hydrocortisone compounding.
- •-Any disorder or situation (decompensation) that, in the opinion of the medical researcher, poses a risk of not complying with the treatment.
研究者
相似试验
尚未招募
4 期
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for PediatricsAdrenal InsufficiencyNCT06435481Hospital Universitari Vall d'Hebron Research Institute35
进行中（未招募）
1 期
Dual-release hydrocortisone compared to immediate-release glucocorticoid replacement therapy in patients with adrenal insufficiency and diabetes mellitus.EUCTR2016-004772-21-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA16
尚未招募
Unknown
A trial for comparing efficacy and safety of oral corticosteriod mini pulse versus oral tofacitinib in arresting disease progression and repigmentation of active vitiligoCTRI/2024/04/065014Research Cell, AIIMS Jodhpur
招募中
3 期
Evaluation of the effects of hydrocortisone on hemodynamic changes in patients under general anesthesiaPatients for elective surgery for upper limb fractures.Fracture of upper limb, level unspecifiedIRCT20170108031818N2Gorgan University of Medical Sciences48
已完成
不适用
Efficacy and safety of Hydrocortison-POS N1% and 2.5% versus Ficortril 0.5% in the treatment of acute inflammation of the ocular surface or adnexa for which steroid treatment is indicatedISRCTN15464650RSAPHARM Arzneimittel GmbH (Germany)411